ArticleHemaSphere2026
Gene expression analysis after BTK and PI3Kδ inhibitor treatment in chronic lymphocytic leukemia identifies cell-surface CXCR4 as a synergistic target for combinatorial therapy.
Gabriela Mladonicka Pavlasova et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.